The Numbers Are In
Authors:
- 9 March 2010
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 121 (9) , 1063-1065
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or DyslipidemiaCirculation, 2010
- Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive ProteinCirculation: Cardiovascular Quality and Outcomes, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in WomenCirculation, 2008
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA, 2002
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialThe Lancet, 2002
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- A PROSPECTIVE STUDY OF PARENTAL HISTORY OF MYOCARDIAL INFARCTION AND CORONARY HEART DISEASE IN WOMENAmerican Journal of Epidemiology, 1986